NORDIL

Cardiology A clinical trial–Nordic Diltiazem Study which evaluated the effect of antihypertensives in Pts with HTN. See Calcium channel blockers.

Mentioned in ?

trial

References in periodicals archive ?

These included the International Nifedipine GITS Study of Intervention as a Goal in Hypertension Treatment (INSIGHT), (23) the Nordic Diltiazem (NORDIL) study, (24) the Australian National Blood Pressure Study 2 (ANBP2), (28) the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial, (26) the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial, (29) and the Irbesartan in Heart Failure with Preserved Systolic Function (I-PRESERVE) study.

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality, in hypertension: the Nordic Diltiazem (NORDIL) study.

Module 1: historical review of evidence-based treatment of hypertension

These were the International Nifedipine-GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT), the Nordic Diltiazem Study (NORDIL), and the second Swedish Trial in Old Patients with Hypertension (STOP-Hypertension-2).

Calcium Antagonists: Costly, Clinically Inferior

(8.) Hansson L, Hedner T, Lund-Johansen P, et al for the NORDIL Study Group.

What we really need to do to reduce cardiovascular events in hypertensive patients: treatment to goal is key--not which antihypertensive you start with, according to this review

Randomized trial of effects of calcium antagonists compared with diuretics and [beta]-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.